Evidence map›Paper›PMID 39128945›Full record

ArticleCommunications biology2024

Platelet extracellular vesicles preserve lymphatic endothelial cell integrity and enhance lymphatic vessel function.

Laurent Vachon, Gabriel Jean, Andreea Milasan, Sara Babran, Elizabeth Lacroix, Dainelys Guadarrama Bello, Louis Villeneuve, Janusz Rak, Antonio Nanci, Teodora Mihalache-Avram and 6 more

Abstract read
In one paragraph

Article in Communications biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Laurent Vachon *Department of Medicine, Faculty of Medicine, Université de Montréal, Montreal, Canada.
Gabriel Jean *Department of Medicine, Faculty of Medicine, Université de Montréal, Montreal, Canada.
Andreea MilasanDepartment of Medicine, Faculty of Medicine, Université de Montréal, Montreal, Canada.
Sara BabranDepartment of Medicine, Faculty of Medicine, Université de Montréal, Montreal, Canada.
Elizabeth LacroixDepartment of Medicine, Faculty of Medicine, Université de Montréal, Montreal, Canada.
Dainelys Guadarrama BelloDepartment of Stomatology, Faculty of Dental Medicine, Université de Montréal, Montreal, Canada.
Louis VilleneuveMontreal Heart Institute, Montreal, Canada.
Janusz RakMcGill University and Research, Institute of the McGill University Health Centre, Montreal, Canada.ORCID 0000-0002-2912-5566
Antonio NanciDepartment of Stomatology, Faculty of Dental Medicine, Université de Montréal, Montreal, Canada.
Teodora Mihalache-AvramMontreal Heart Institute, Montreal, Canada.
Jean-Claude TardifDepartment of Medicine, Faculty of Medicine, Université de Montréal, Montreal, Canada.ORCID 0000-0002-8200-8983
Vincent FinnertyMontreal Heart Institute, Montreal, Canada.
Matthieu RuizDepartment of Nutrition, Faculty of Medicine, Université de Montréal, Montreal, Canada.ORCID 0000-0003-0561-0695
Eric BoilardCentre de Recherche ARThrite - Arthrite, Recherche, Traitements, Université Laval, Québec, Québec, Canada.ORCID 0000-0001-6319-6432
Nolwenn TessierDepartment of Medicine, Faculty of Medicine, Université de Montréal, Montreal, Canada.
Catherine MartelDepartment of Medicine, Faculty of Medicine, Université de Montréal, Montreal, Canada. catherine.martel@icm-mhi.org.ORCID 0000-0003-3349-1646

Funding

DEVELOPMENT OF A HIGHLY COMPLIANT VASCULAR GRAFTR43HL034933 · NHLBI · THORATEC LABORATORIES CORPORATION · PI LITWAK, PHILIP · 1985 to 1985
–
DEVELOPMENT OF A HIGHLY COMPLIANT VASCULAR GRAFTR44HL034933 · NHLBI · THORATEC LABORATORIES CORPORATION · PI LITWAK, PHILIP · 1987 to 1988
–
Gouvernement du Canada | Natural Sciences and Engineering Research Council of Canada (Conseil de Recherches en Sciences Naturelles et en Génie du Canada) RGPIN-2016-05331Heart and Stroke Foundation of Canada (Heart and Stroke Foundation) G-23-0034933
6 · The paper itself

Abstract

Lymphatic vessels are essential for preventing the accumulation of harmful components within peripheral tissues, including the artery wall. Various endogenous mechanisms maintain adequate lymphatic function throughout life, with platelets being essential for preserving lymphatic vessel integrity. However, since lymph lacks platelets, their impact on the lymphatic system has long been viewed as restricted to areas where lymphatics intersect with blood vessels. Nevertheless, platelets can also exert long range effects through the release of extracellular vesicles (EVs) upon activation. We observed that platelet EVs (PEVs) are present in lymph, a compartment to which they could transfer regulatory effects of platelets. Here, we report that PEVs in lymph exhibit a distinct signature enabling them to interact with lymphatic endothelial cells (LECs). In vitro experiments show that the internalization of PEVs by LECs maintains their functional integrity. Treatment with PEVs improves lymphatic contraction capacity in atherosclerosis-prone mice. We suggest that boosting lymphatic pumping with exogenous PEVs offers a novel therapeutic approach for chronic inflammatory diseases characterized by defective lymphatics.

Indexed as

Blood PlateletsEndothelial CellsExtracellular VesiclesLymphatic VesselsAnimalsFemaleHumansMaleMiceMice, Inbred C57BL

Identifiers

PMID39128945
PMCPMC11317532

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.